Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries

Kidney International

Volumn 69, Issue 3, 2006, Pages 553-559

  Nishimura, M ^a,d   Murase, M ^a   Hashimoto, T ^a   Kobayashi, H ^a   Yamazaki, S ^a   Imai, R ^a   Okino, K ^a   Fujita, H ^b   Inoue, N ^b   Takahashi, H ^c   Ono, T ^a  

^a Toujinkai Hospital   (Japan)

^b KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d Toujinkai Hospital   (Japan)

Author keywords

Fatty acid; Heart failure; Hemodialysis; Homeostasis model assessment index; Insulin resistance; Myocardial scintigraphy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123;

ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE METABOLISM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CORONARY DISEASE; CORONARY VESSELS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; FATTY ACIDS; FEMALE; GLUCOSE; HEART FAILURE, CONGESTIVE; HOMEOSTASIS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; IODOBENZENES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MYOCARDIUM; REGRESSION ANALYSIS; RENAL DIALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 31544436913     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000100     Document Type: Article

References (48)

1. Hutchinson TA, Thomas DC, MacGaibbon B. Predicting survival in adults with end-stage renal disease: an age equivalence index. Ann Intern Med 1982; 96: 417-423.
2. U.S. Renal Data System 1992. Annual Report, IV, Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 1992; 20: 32-38.
3. Harnett JD, Foley RN, Kent GM et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890.
4. Cheung AK, Sarnak MJ, Yan G et al. Cardiac diseases in maintenance hemodialysis patients: results of the MEMO Study. Kidney Int 2004; 65: 2380-2389.
5. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993; 44: 617-621.
6. Rostand SG, Rutsky EA. Ischemic heart disease in chronic renal failure: management considerations. Semin Dial 1989; 2: 98-101.
7. Nishimura M, Hashimoto T, Kobayashi H et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 2004; 66: 811-819.
8. Foley RN, Parfrey PS, Harnett JD et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61.
9. Foley RN, Parfrey PS, Harnett JD et al. Impact of hypertension on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-1385.
10. London GM, Fabiani E, Marchais SJ et al. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 1987; 31: 973-980.
11. Neely R, Rovetto J, Oram F. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15: 289-299.
12. Lopaschuk GD, Belke DD, Gamble J et al. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213: 263-276.
13. Yamamichi Y, Kusuoka H, Morishita K et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995; 36: 1043-1050.
14. Fujibayashi Y, Yonekura Y, Takemura Y et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl) -3-(R,S)methyl pentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822.
15. Fujibayashi Y, Nohara R, Hosokawa R et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996; 37: 757-761.
16. Nohara R, Okuda K, Ogino M et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996; 37: 1403-1407.
17. Hosokawa R, Nohara R, Fujibayashi Y et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT. J Nucl Med 1997; 38: 1857-1863.
18. Tamaki N, Kawamoto M, Yonekura Y et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667.
19. Kataoka K, Nohara R, Hosokawa R et al. Myocardial lipid metabolism in compensated and advanced stages of heart failure: evaluation by canine pacing model with BMIPP. J Nucl Med 2001; 42: 124-129.
20. Fenchel G, Storf R, Michel J, Hoffmeister HE. Relationship between the high-energy phosphate content and various left ventricular functional parameters of the normal and hypertrophied heart after global ischemia and reperfusion. Thorac Cardiovasc Sur 1988; 36: 75-79.
21. Beer M, Spindler M, Sandstede JJ et al. Detection of myocardial infarction by acquisition-weighted 31P-MR spectroscopy in humans. J Magn Reson Imaging 2004; 20: 798-802.
22. Neubaurer E. Über hyperglykaemia bei hochdrucknephritis und die beziehungen zwischen glykaemie und glycosurie bein diabetes mellitus. Biochem Z 1910; 25: 285-298.
23. DeFronzo RA, Alvestrand A, Smith D et al. Carbohydrate metabolism in uremia. Medicine 1973; 52: 469-481.
24. Mark RHK. Renal disease, insulin resistance and glucose intolerance. Diabetes 1994; 2: 19-28.
25. DeFronzo RA, Alvestrand A, Hendler DSR. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568.
26. Wheatcroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003; 20: 255-268.
27. Jiang ZY, Lin YW, Clemont A et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999; 104: 447-457.
28. Balletshofer BM, Ritting K, Enderle MD et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000; 101: 1780-1784.
29. Higashi Y, Oshima T, Sasaki N et al. Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension 1997; 29: 280-285.
30. Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycemia. Diabetologia 1997; 40: 238-243.
31. Serne EH, Stehouwer CD, ter Maaten JC et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999; 99: 896-902.
32. Dagres N, Saller B, Haude M et al. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol 2004; 61: 724-731.
33. Amann K, Wiest G, Neusüß R et al. Changes in vascular architecture independent of blood pressure in experimental uremia. Vascular hypertrophy in uremia is independent of hypertension. Am J Hypertens 1995; 8: 409-417.
34. Barenbrock M, Spieker C, Laske V et al. Studies of vessel wall properties in hemodialysis patients. Kidney Int 1994; 45: 1397-1400.
35. Amann K, Wiest G, Zimmer G et al. Reduced capillary density in the myocardium of uremic rats - a stereological study. Kidney Int 1992; 42: 1079-1085.
36. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018-1022.
37. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
38. Festa A, D'Agostino Jr R, Howard G et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
39. Temelkova-Kurktschiev T, Henkel E, Koehler C et al. Subclinical inflammation in newly detected type II diabetes and impaired glucose tolerance. Diabetologia 2002; 45: 151.
40. Defronzo RA, Tobin JD, Andres R. The glucose clamp technique: a method for the quantification of beta-cell sensitivity to glucose and tissue sensitivity to insulin. Am J Physiol 1979; 237: E214-E223.
41. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
42. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16: 895-906.
43. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
44. Bonora E, Targger G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
45. Emoto M, Nishizawa Y, Maekawa K et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-822.
46. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001; 89: 348-349.
47. Katsuki A, Sumida Y, Urakawa H et al. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. J Clin Endocrinol Metab 2002; 87: 5332-5335.
48. Schiller NB, Shah P, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.